Skip to main content

Table 1 Group differences in demographic and biological parameters

From: Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines

 

Lean

Obese

p-value

Gender (% female)

58.3

55.6

0.832

Race/Ethnicity

  

χ2 = 1.02

 White (%)

33.3

38.9

 

 Hispanic (%)

25.0

27.8

 

 African American (%)

25.0

25.0

 

 Asian (%)

16.7

8.3

 

Age (yrs)

17.2 ± 0.4

17.5 ± 0.3

0.396

Grade

11.2 ± 0.4

11.4 ± 0.2

0.708

BMI (kg/m2)

21.5 ± 0.5

37.4 ± 1.2

0.000**

Waist Circumference (cm)

76.8 ± 1.2

112.2 ± 2.8

0.000**

Waist:Height

0.45 ± 0.01

0.66 ± 0.01

0.000**

Waist:Hip

0.85 ± 0.01

0.94 ± 0.01

0.000**

Glucose (mg/dL)

73.5 ± 1.4

77.3 ± 1.5

0.083

Insulin (IU/mL)

7.4 ± 0.6

18.4 ± 2.0

0.000**

HOMA-IR

1.3 ± 0.1

3.5 ± 0.4

0.000**

Hemoglobin A1C (%)

5.1 ± 0.1

5.4 ± 0.1

0.000**

Total cholesterol (mg/dL)

160.5 ± 5.9

164.1 ± 5.3

0.662

LDL (mg/dL)

91.5 ± 5.1

102.6 ± 4.7

0.125

HDL (mg/dL)

55.0 ± 2.5

43.7 ± 1.5

0.000**

Triglycerides (mg/dL)

70.6 ± 5.6

89.4 ± 7.2

0.064

Systolic BP (mmHg)

101.3 ± 1.9

115.3 ± 2.0

0.000**

Diastolic BP (mmHg)

63.2 ± 1.7

68.0 ± 1.5

0.036*

  1. *Denotes a p-value of >0.05; **denotes a p-value of ≤0.010.
  2. Body mass index (BMI); homeostatic model assessment of insulin resistance (HOMA-IR); low density lipoprotein (LDL); high density lipoprotein (HDL); blood pressure (BP).